255 related articles for article (PubMed ID: 29995590)
1. A Rnd3/p190RhoGAP pathway regulates RhoA activity in idiopathic pulmonary fibrosis fibroblasts.
Monaghan-Benson E; Wittchen ES; Doerschuk CM; Burridge K
Mol Biol Cell; 2018 Sep; 29(18):2165-2175. PubMed ID: 29995590
[TBL] [Abstract][Full Text] [Related]
2. Fibroblast-matrix interplay: Nintedanib and pirfenidone modulate the effect of IPF fibroblast-conditioned matrix on normal fibroblast phenotype.
Epstein Shochet G; Wollin L; Shitrit D
Respirology; 2018 Aug; 23(8):756-763. PubMed ID: 29532550
[TBL] [Abstract][Full Text] [Related]
3. RhoA signaling modulates cyclin D1 expression in human lung fibroblasts; implications for idiopathic pulmonary fibrosis.
Watts KL; Cottrell E; Hoban PR; Spiteri MA
Respir Res; 2006 Jun; 7(1):88. PubMed ID: 16776827
[TBL] [Abstract][Full Text] [Related]
4. Rnd proteins function as RhoA antagonists by activating p190 RhoGAP.
Wennerberg K; Forget MA; Ellerbroek SM; Arthur WT; Burridge K; Settleman J; Der CJ; Hansen SH
Curr Biol; 2003 Jul; 13(13):1106-15. PubMed ID: 12842009
[TBL] [Abstract][Full Text] [Related]
5. Comparison of the antifibrotic effects of the pan-histone deacetylase-inhibitor panobinostat versus the IPF-drug pirfenidone in fibroblasts from patients with idiopathic pulmonary fibrosis.
Korfei M; Stelmaszek D; MacKenzie B; Skwarna S; Chillappagari S; Bach AC; Ruppert C; Saito S; Mahavadi P; Klepetko W; Fink L; Seeger W; Lasky JA; Pullamsetti SS; Krämer OH; Guenther A
PLoS One; 2018; 13(11):e0207915. PubMed ID: 30481203
[TBL] [Abstract][Full Text] [Related]
6. Compromised peroxisomes in idiopathic pulmonary fibrosis, a vicious cycle inducing a higher fibrotic response via TGF-β signaling.
Oruqaj G; Karnati S; Vijayan V; Kotarkonda LK; Boateng E; Zhang W; Ruppert C; Günther A; Shi W; Baumgart-Vogt E
Proc Natl Acad Sci U S A; 2015 Apr; 112(16):E2048-57. PubMed ID: 25848047
[TBL] [Abstract][Full Text] [Related]
7. The RhoA GEF Syx is a target of Rnd3 and regulated via a Raf1-like ubiquitin-related domain.
Goh LL; Manser E
PLoS One; 2010 Aug; 5(8):e12409. PubMed ID: 20811643
[TBL] [Abstract][Full Text] [Related]
8. A Novel Antifibrotic Mechanism of Nintedanib and Pirfenidone. Inhibition of Collagen Fibril Assembly.
Knüppel L; Ishikawa Y; Aichler M; Heinzelmann K; Hatz R; Behr J; Walch A; Bächinger HP; Eickelberg O; Staab-Weijnitz CA
Am J Respir Cell Mol Biol; 2017 Jul; 57(1):77-90. PubMed ID: 28257580
[TBL] [Abstract][Full Text] [Related]
9. CCN5 overexpression inhibits profibrotic phenotypes via the PI3K/Akt signaling pathway in lung fibroblasts isolated from patients with idiopathic pulmonary fibrosis and in an in vivo model of lung fibrosis.
Zhang L; Li Y; Liang C; Yang W
Int J Mol Med; 2014 Feb; 33(2):478-86. PubMed ID: 24276150
[TBL] [Abstract][Full Text] [Related]
10. Histopathological and molecular analysis of idiopathic pulmonary fibrosis lungs from patients treated with pirfenidone or nintedanib.
Zhang Y; Jones KD; Achtar-Zadeh N; Green G; Kukreja J; Xu B; Wolters PJ
Histopathology; 2019 Jan; 74(2):341-349. PubMed ID: 30152895
[TBL] [Abstract][Full Text] [Related]
11. Dysregulated Collagen Homeostasis by Matrix Stiffening and TGF-β1 in Fibroblasts from Idiopathic Pulmonary Fibrosis Patients: Role of FAK/Akt.
Giménez A; Duch P; Puig M; Gabasa M; Xaubet A; Alcaraz J
Int J Mol Sci; 2017 Nov; 18(11):. PubMed ID: 29144435
[TBL] [Abstract][Full Text] [Related]
12. A-kinase anchoring protein-Lbc promotes pro-fibrotic signaling in cardiac fibroblasts.
Cavin S; Maric D; Diviani D
Biochim Biophys Acta; 2014 Feb; 1843(2):335-45. PubMed ID: 24269843
[TBL] [Abstract][Full Text] [Related]
13. SHP-2 positively regulates myogenesis by coupling to the Rho GTPase signaling pathway.
Kontaridis MI; Eminaga S; Fornaro M; Zito CI; Sordella R; Settleman J; Bennett AM
Mol Cell Biol; 2004 Jun; 24(12):5340-52. PubMed ID: 15169898
[TBL] [Abstract][Full Text] [Related]
14. Downregulation of FAK-related non-kinase mediates the migratory phenotype of human fibrotic lung fibroblasts.
Cai GQ; Zheng A; Tang Q; White ES; Chou CF; Gladson CL; Olman MA; Ding Q
Exp Cell Res; 2010 May; 316(9):1600-9. PubMed ID: 20109444
[TBL] [Abstract][Full Text] [Related]
15. Regulation of Cellular Senescence Is Independent from Profibrotic Fibroblast-Deposited ECM.
Blokland KEC; Habibie H; Borghuis T; Teitsma GJ; Schuliga M; Melgert BN; Knight DA; Brandsma CA; Pouwels SD; Burgess JK
Cells; 2021 Jun; 10(7):. PubMed ID: 34209854
[TBL] [Abstract][Full Text] [Related]
16. The GTPase-deficient Rnd proteins are stabilized by their effectors.
Goh LL; Manser E
J Biol Chem; 2012 Sep; 287(37):31311-20. PubMed ID: 22807448
[TBL] [Abstract][Full Text] [Related]
17. Anti-fibrotic effects of nintedanib in lung fibroblasts derived from patients with idiopathic pulmonary fibrosis.
Hostettler KE; Zhong J; Papakonstantinou E; Karakiulakis G; Tamm M; Seidel P; Sun Q; Mandal J; Lardinois D; Lambers C; Roth M
Respir Res; 2014 Dec; 15(1):157. PubMed ID: 25496490
[TBL] [Abstract][Full Text] [Related]
18. Reversion of in vivo fibrogenesis by novel chromone scaffolds.
Kim HS; Yoon YM; Meang MK; Park YE; Lee JY; Lee TH; Lee JE; Kim IH; Youn BS
EBioMedicine; 2019 Jan; 39():484-496. PubMed ID: 30611717
[TBL] [Abstract][Full Text] [Related]
19. ATP-induced fibrogenic pathway in circulating cells obtained by idiopathic pulmonary fibrotic (IPF) patients is not blocked by nintedanib and pirfenidone.
Colarusso C; Falanga A; Di Caprio S; Terlizzi M; D'Andria E; Antonio M; Maiolino P; Sorrentino R
Biomed Pharmacother; 2024 Jul; 176():116896. PubMed ID: 38876049
[TBL] [Abstract][Full Text] [Related]
20. Upregulation of RGS2: a new mechanism for pirfenidone amelioration of pulmonary fibrosis.
Xie Y; Jiang H; Zhang Q; Mehrotra S; Abel PW; Toews ML; Wolff DW; Rennard S; Panettieri RA; Casale TB; Tu Y
Respir Res; 2016 Aug; 17(1):103. PubMed ID: 27549302
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
